Raymond James Financial Services Advisors, Inc. Moderna, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 84,193 shares of MRNA stock, worth $4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
84,193
Previous 76,931
9.44%
Holding current value
$4 Million
Previous $9.14 Million
38.41%
% of portfolio
0.01%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding MRNA
# of Institutions
953Shares Held
240MCall Options Held
10.6MPut Options Held
18.7M-
Baillie Gifford & CO42.5MShares$2.02 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.2MShares$1.91 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.21 Billion0.07% of portfolio
-
State Street Corp Boston, MA16.8MShares$801 Million0.05% of portfolio
-
Theleme Partners LLP London, X07.23MShares$343 Million28.47% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $18.6B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...